Avecho Biotechnology Limited (AU:AVE) has released an update.
Avecho Biotechnology Limited announced its Annual General Meeting details and showcased its proprietary drug delivery system, TPM®, aimed at enhancing the absorption of drugs and nutrients in human and animal health sectors. The company is advancing TPM® applications in various products, including those for human health and improving livestock feed efficiency. The AGM will feature addresses from the Chair and CEO, highlighting the company’s recent milestones and future projects.
For further insights into AU:AVE stock, check out TipRanks’ Stock Analysis page.
